We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+32.77%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$85.3M
Cap. Flow
+$20.6M
Cap. Flow %
7.33%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALPN
Alpine Immune Sciences Inc
ALPN
+$20.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$1.7B
$129M 45.97%
3,688,448
– –
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
$39.2M 13.98%
2,600,014
– –
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
$26.8M 9.57%
2,173,593
– –
ALPN
4
DELISTED
Alpine Immune Sciences Inc
ALPN
$25.5M 9.1%
+2,199,011
New +$20.6M
COLL icon
5
Collegium Pharmaceutical
COLL
$820M
$19.8M 7.06%
1,887,332
– –
IOVA icon
6
Iovance Biotherapeutics
IOVA
$3.74B
$17M 6.05%
2,188,331
– –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$12.6M 4.48%
202,803
– –
CDTX
8
DELISTED
Cidara Therapeutics
CDTX
$10.6M 3.79%
65,613
– –

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q3 2017 Portfolio in Review

As of Q3 2017, Frazier Management held 8 positions worth $280M, up 44% from $195M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management deployed $20.6M of net new capital in Q3 2017, opening 1 new position. Its largest new stake was Alpine Immune Sciences Inc: 2,199,011 shares worth $25.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Frazier Management's largest Q3 2017 buy was Alpine Immune Sciences Inc: 2,199,011 shares worth $25.5M.
  • Frazier Management's ten largest holdings make up 100% of its $280M portfolio in Q3 2017.
  • Frazier Management opened 1 new position and closed 0 in Q3 2017.
  • Frazier Management's portfolio value rose 44% quarter-over-quarter to $280M.

Based on Frazier Management's 13F filing for Q3 2017, filed 13 Nov 2017.